Back to today’s briefing

Story perspectives

Pro-Life Centers Challenge Mifepristone Safety Claims Amid Controversy

5/1/2025

28 6

Summary

Story summary

Pro-life pregnancy centers are taking a stand against Democratic attorneys general, disputing claims that mifepristone can be reversed with progesterone. New research reveals a staggering adverse reaction rate of nearly 11% after mifepristone use, sharply contradicting the FDA's earlier assertion of under 0.5%. The contentious debate over the drug's safety and access rages on.

1 of 1

Story summary

Pro-life pregnancy centers are taking a stand against Democratic attorneys general, disputing claims that mifepristone can be reversed with progesterone. New research reveals a staggering adverse reaction rate of nearly 11% after mifepristone use, sharply contradicting the FDA's earlier assertion of under 0.5%. The contentious debate over the drug's safety and access rages on.